S

StrideBio, Inc

30 employees

StrideBio is a gene therapy company that develops genetic medicines with curative potential for patients with devastating conditions.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
AAV Vectors
Health Care
Gene Therapy
Therapeutics
Information Technology

Date founded

2015

Funding rounds raised

Total raised

$82M

from 10 investors over 10 rounds

S

StrideBio, Inc raised $82M on March 16, 2021

Investors: UCB Ventures, Octagon Capital Advisors, Northpond Ventures, UF Innovate | Ventures, Novo Holdings, Takeda UK Limited, CaaS Capital Management, Pontifax Venture Capital and Sarepta Therapeutics

S

StrideBio, Inc raised $16M on June 13, 2018

Investors: Takeda UK Limited

FAQ